Cargando…
A Validation Study of a Noninvasive Lactate Threshold Device
The lactate threshold is considered a key marker of endurance exercise performance and identification of this threshold is important in writing an exercise training program. Unfortunately, assessment of the lactate threshold has traditionally required venous or capillary blood samples and a speciali...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Berkeley Electronic Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355126/ https://www.ncbi.nlm.nih.gov/pubmed/30761197 |
_version_ | 1783391300900356096 |
---|---|
author | MCMORRIES, REBECCA M. JOUBERT, DUSTIN P. JONES, ERIC J. FARIES, MARK D. |
author_facet | MCMORRIES, REBECCA M. JOUBERT, DUSTIN P. JONES, ERIC J. FARIES, MARK D. |
author_sort | MCMORRIES, REBECCA M. |
collection | PubMed |
description | The lactate threshold is considered a key marker of endurance exercise performance and identification of this threshold is important in writing an exercise training program. Unfortunately, assessment of the lactate threshold has traditionally required venous or capillary blood samples and a specialized meter to assess blood lactate concentrations. Recently, a consumer grade, non-invasive device was developed to determine muscle oxygenation and estimate the lactate threshold. PURPOSE: The aim of this study was to assess the validity of a noninvasive lactate threshold device (NID) to determine lactate threshold heart rate (LTHR). METHODS: Twenty-one recreational athletes (14 females, 39 ± 7 years, 29.1 ± 5.2% fat, 37.8 ± 6.0 ml·kg(−1)·min(−1); 7 males, 42 ± 9 years, 16.8 ± 2.2% fat, 45.9 ± 6.4 ml·kg(−1)·min(−1)) completed a personalized graded exercise test on a treadmill. All participants wore the NID and blood lactate samples were taken at the end of 3-minute stages. LTHR was then calculated using two traditional methods (4 mmol/L and >1 mmol/L increase) and compared against the same heart rate values calculated by the NID. RESULTS: No significant differences (p = .87) were found in LTHR between the NID and the traditional lactate methods (NID: 167 ± 9 bpm, 4 mmol/L: 167 ± 12 bpm, >1 mmol/L: 167 ± 12 bpm). CONCLUSIONS: This study provides preliminary support for the validity of the NID for estimation of LTHR. |
format | Online Article Text |
id | pubmed-6355126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Berkeley Electronic Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63551262019-02-11 A Validation Study of a Noninvasive Lactate Threshold Device MCMORRIES, REBECCA M. JOUBERT, DUSTIN P. JONES, ERIC J. FARIES, MARK D. Int J Exerc Sci Original Research The lactate threshold is considered a key marker of endurance exercise performance and identification of this threshold is important in writing an exercise training program. Unfortunately, assessment of the lactate threshold has traditionally required venous or capillary blood samples and a specialized meter to assess blood lactate concentrations. Recently, a consumer grade, non-invasive device was developed to determine muscle oxygenation and estimate the lactate threshold. PURPOSE: The aim of this study was to assess the validity of a noninvasive lactate threshold device (NID) to determine lactate threshold heart rate (LTHR). METHODS: Twenty-one recreational athletes (14 females, 39 ± 7 years, 29.1 ± 5.2% fat, 37.8 ± 6.0 ml·kg(−1)·min(−1); 7 males, 42 ± 9 years, 16.8 ± 2.2% fat, 45.9 ± 6.4 ml·kg(−1)·min(−1)) completed a personalized graded exercise test on a treadmill. All participants wore the NID and blood lactate samples were taken at the end of 3-minute stages. LTHR was then calculated using two traditional methods (4 mmol/L and >1 mmol/L increase) and compared against the same heart rate values calculated by the NID. RESULTS: No significant differences (p = .87) were found in LTHR between the NID and the traditional lactate methods (NID: 167 ± 9 bpm, 4 mmol/L: 167 ± 12 bpm, >1 mmol/L: 167 ± 12 bpm). CONCLUSIONS: This study provides preliminary support for the validity of the NID for estimation of LTHR. Berkeley Electronic Press 2019-01-01 /pmc/articles/PMC6355126/ /pubmed/30761197 Text en |
spellingShingle | Original Research MCMORRIES, REBECCA M. JOUBERT, DUSTIN P. JONES, ERIC J. FARIES, MARK D. A Validation Study of a Noninvasive Lactate Threshold Device |
title | A Validation Study of a Noninvasive Lactate Threshold Device |
title_full | A Validation Study of a Noninvasive Lactate Threshold Device |
title_fullStr | A Validation Study of a Noninvasive Lactate Threshold Device |
title_full_unstemmed | A Validation Study of a Noninvasive Lactate Threshold Device |
title_short | A Validation Study of a Noninvasive Lactate Threshold Device |
title_sort | validation study of a noninvasive lactate threshold device |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355126/ https://www.ncbi.nlm.nih.gov/pubmed/30761197 |
work_keys_str_mv | AT mcmorriesrebeccam avalidationstudyofanoninvasivelactatethresholddevice AT joubertdustinp avalidationstudyofanoninvasivelactatethresholddevice AT jonesericj avalidationstudyofanoninvasivelactatethresholddevice AT fariesmarkd avalidationstudyofanoninvasivelactatethresholddevice AT mcmorriesrebeccam validationstudyofanoninvasivelactatethresholddevice AT joubertdustinp validationstudyofanoninvasivelactatethresholddevice AT jonesericj validationstudyofanoninvasivelactatethresholddevice AT fariesmarkd validationstudyofanoninvasivelactatethresholddevice |